Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Indolent lymphomas: pushing the pace with novel agents

Caron A. Jacobson

Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 279–286.

https://doi.org/10.1182/hematology.2019000032

Published: 2019

Journal Articles

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Stephen M. Ansell

Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 618–621.

https://doi.org/10.1182/asheducation-2017.1.618

Published: 2017

Journal Articles

Frontline therapy and role of high-dose consolidation in mantle cell lymphoma

Simon Rule

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 419–424.

https://doi.org/10.1182/asheducation-2016.1.419

Published: 2016

Journal Articles

Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum

John T. Sandlund, Mike G. Martin

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 589–597.

https://doi.org/10.1182/asheducation-2016.1.589

Published: 2016

Journal Articles

Advances in therapies for non-Hodgkin lymphoma in children

Rachel Kobos, William Terry

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 522–528.

https://doi.org/10.1182/asheducation.V2015.1.522.3916185

Published: 2015

Journal Articles

B-cell receptor pathway modulators in NHL

Kristie A. Blum

Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 82–91.

https://doi.org/10.1182/asheducation-2015.1.82

Published: 2015

Journal Articles

Optimal disease surveillance strategies in non-Hodgkin lymphoma

Jonathon B. Cohen, Christopher R. Flowers

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 481–487.

https://doi.org/10.1182/asheducation-2014.1.481

Published: 2014

Journal Articles

Hepatitis C virus-associated B-cell non-Hodgkin lymphomas

Barbara Vannata, Emanuele Zucca

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 590–598.

https://doi.org/10.1182/asheducation-2014.1.590

Published: 2014

Journal Articles

HIV-associated non-Hodgkin lymphoma: viral origins and therapeutic options

Amrita Krishnan, John A. Zaia

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 584–589.

https://doi.org/10.1182/asheducation-2014.1.584

Published: 2014

Journal Articles

Transplantation for mantle cell lymphoma: is it the right thing to do?

Michael E. Williams

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 568–574.

https://doi.org/10.1182/asheducation-2013.1.568

Published: 2013

Journal Articles

The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question

Lisa K. Hicks, Harriet Bering, Kenneth R. Carson, Judith Kleinerman, Vishal Kukreti, Alice Ma, Brigitta U. Mueller, Sarah H. O'Brien, Marcelo Pasquini, Ravindra Sarode, Lawrence Solberg, Jr, Adam E. Haynes, Mark A. Crowther

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 9–14.

https://doi.org/10.1182/asheducation-2013.1.9

Published: 2013

Journal Articles

Current treatment standards and emerging strategies in mantle cell lymphoma

Martin Dreyling, Wolfgang Hiddemann, for The European MCL Network

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 542–551.

https://doi.org/10.1182/asheducation-2009.1.542

Published: 2009

Journal Articles

Antibody Therapy in Aggressive Lymphomas

Thomas M. Habermann

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 257–264.

https://doi.org/10.1182/asheducation-2007.1.257

Published: 2007

Journal Articles

Mantle Cell Lymphoma: Identifying Novel Molecular Targets in Growth and Survival Pathways

Owen A. O’Connor

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 270–276.

https://doi.org/10.1182/asheducation-2007.1.270

Published: 2007

Journal Articles

Optimal Use of Prognostic Factors in Non-Hodgkin Lymphoma

Laurie H. Sehn

Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 295–302.

https://doi.org/10.1182/asheducation-2006.1.295

Published: 2006

Journal Articles

Reduced-Intensity Regimens in Allogeneic Stem-Cell Transplantation for Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Issa F. Khouri

Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 390–397.

https://doi.org/10.1182/asheducation-2006.1.390

Published: 2006

Journal Articles

Pathobiology of Peripheral T-cell Lymphomas

Elaine S. Jaffe

Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 317–322.

https://doi.org/10.1182/asheducation-2006.1.317

Published: 2006

Journal Articles

The Ubiquitin Proteasome Pathway from Bench to Bedside

Robert Z. Orlowski

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 220–225.

https://doi.org/10.1182/asheducation-2005.1.220

Published: 2005

Journal Articles

Hematopathology Approaches to Diagnosis and Prognosis of Indolent B-Cell Lymphomas

Randy D. Gascoyne

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 299–306.

https://doi.org/10.1182/asheducation-2005.1.299

Published: 2005

Journal Articles

Biology and Treatment of Epstein-Barr Virus–Associated Non-Hodgkin Lymphomas

Helen E. Heslop

Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 260–266.

https://doi.org/10.1182/asheducation-2005.1.260

Published: 2005

NARROW

Indolent lymphomas: pushing the pace with novel agents

Harnessing the power of the immune system in non-Hodgkin lymphoma: immunomodulators, checkpoint inhibitors, and beyond

Frontline therapy and role of high-dose consolidation in mantle cell lymphoma

Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum

Advances in therapies for non-Hodgkin lymphoma in children

B-cell receptor pathway modulators in NHL

Optimal disease surveillance strategies in non-Hodgkin lymphoma

Hepatitis C virus-associated B-cell non-Hodgkin lymphomas

HIV-associated non-Hodgkin lymphoma: viral origins and therapeutic options

Transplantation for mantle cell lymphoma: is it the right thing to do?

The ASH Choosing Wisely® campaign: five hematologic tests and treatments to question

Current treatment standards and emerging strategies in mantle cell lymphoma

Antibody Therapy in Aggressive Lymphomas

Mantle Cell Lymphoma: Identifying Novel Molecular Targets in Growth and Survival Pathways

Optimal Use of Prognostic Factors in Non-Hodgkin Lymphoma

Reduced-Intensity Regimens in Allogeneic Stem-Cell Transplantation for Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Pathobiology of Peripheral T-cell Lymphomas

The Ubiquitin Proteasome Pathway from Bench to Bedside

Hematopathology Approaches to Diagnosis and Prognosis of Indolent B-Cell Lymphomas

Biology and Treatment of Epstein-Barr Virus–Associated Non-Hodgkin Lymphomas

ASH Publications

American Society of Hematology

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only